MedCity News

The shopping cart is full of white capsules with medicine and some of the capsules are lying on the floor.

Why HHS Scrapping Its 340B Rebate Program Is a Win For Providers

Chamber Secures $60M to Advance Value-Based Cardiology

Chamber's Series A round was led by Frist Cressey Ventures, with participation from General Catalyst, AlleyCorp, American Family Ventures, Company Ventures, Optum Ventures, Healthworx Ventures and Black Opal Ventures.

By Marissa Plescia

BioPharma, Pharma

Bayer Reveals Data That Could Make Stroke Prevention Drug Its Next Blockbuster Product

Bayer’s asundexian, a Factor XIa inhibitor, reduced the risk of secondary stroke by 26% without increasing bleeding risk in a Phase 3 clinical trial. The once-daily pill is at the front of an emerging class of medicines that includes drug candidates from Regeneron Pharmaceuticals and partners Bristol Myers Squibb and Johnson & Johnson.

By Frank Vinluan

MedCity Influencers

Doctors and the Virtual Medical Revolution and Technological Advances Artificial Intelligence (AI) Deep Learning for Medical Research and Future Health Technology

Keeping Honest in Healthcare: Engineering Accountability into AI

When AI is honest and acts as a connector in healthcare workflows, clinician time is freed up, accuracy is ensured, and revenue is protected.

By Ajai Sehgal

Latest Video

Latest News

MedCity Influencers

The Critical Challenges Facing Post-Acute Care and Why Agentic AI Is No Longer Optional

The real value of AI in post-acute care is not how quickly it can process documents, but whether it can provide foresight. That means understanding how clinical indicators, regulatory requirements, and reimbursement rules interact, and identifying risk before it turns into a denial or an audit finding.

By Cory Evans

Health Tech

The Digital Health M&A Wave Is Finally Here

Digital health is entering a more mature phase in 2026 as consolidation accelerates through targeted M&A, driven by the need for scale, artificial intelligence and pressure from payers, investors say.

By Marissa Plescia

Artificial Intelligence, Startups, Health Tech, Providers

Do Ambient Scribe Startups Have a Future Now That Epic Launched Its Own Tool?

Epic’s rollout of a built-in AI charting tool is intensifying competition in the already crowded ambient AI scribe market, forcing standalone vendors to sharpen their differentiation in an Epic-dominated health system landscape.

By Katie Adams

BioPharma, Pharma

Eikon Therapeutics Continues the IPO Parade, Raising $381M for Cancer Drug Clinical Trials

Eikon Therapeutics’ IPO haul will support a lead program that could expand the scope of cancer immunotherapy. Eikon’s stock market debut builds on growing IPO momentum, following upsized offerings from Aktis Oncology and Veradermics.

By Frank Vinluan

Artificial Intelligence

Debunked Episode 23: Companies Vie for Healthcare AI Dominance

The conversation between MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, highlighted news from the J.P. Morgan Healthcare Conference, particularly how technology and biopharma companies are shaping AI in healthcare.

By Stephanie Baum

The Power of One: Redefining Healthcare with an AI-Driven Unified Platform

In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.

By David Cohen, Chief Product & Technology Officer, Greenway Health

MedCity Influencers

The Illusion of Diversion Data: Why Confirmed Diversion Counts Misrepresent True Risk

Confirmed diversion cases do not equal true prevalence - they are directly dependent on investigative proficiency, tooling, and the bandwidth of the teams doing the work.

By Lauren Forni

MedCity Influencers

Multi Layered Paper Craft Check Mark and Cross Mark in Concentric Circles on Green and Red Background Front View, Right or Wrong Choosing Concept.

Choosing the Right Methods for the Right AI to Accelerate Prior Authorizations

With regulatory scrutiny intensifying and the demand for speed, compliance, and clarity growing, understanding the nuanced differences between AI approaches is essential for payers, providers, and patients alike.

By Matt Cunningham

Devices & Diagnostics

DexCom’s CEO Believes Diabetics On GLP-1s Should Also Wear CGMs

Jake Leach became DexCom's chief executive on January 1 and is trying to write the turnaround story of this innovative medtech company. One story to tell is how CGMs should be a no-brainer for type 2 diabetes patients on GLP-1 weight loss drugs.

By Arundhati Parmar

BioPharma, Pharma

Baldness Biotech Veradermics Prices $256M IPO for Pivotal Tests of Pill for Hair Loss

Veradermics’s drug, a pill version of the topical hair loss product minoxidil, was developed with technology intended to avoid the cardiovascular risks associated with oral dosing of this compound. The first of three pivotal clinical trials is expected to yield preliminary data in the first half of 2026.

By Frank Vinluan

Health Tech, Startups, Consumer / Employer, Providers

A hand holding a magnifying glass over a blue unicorn on pink background.

Digital Health’s Latest Unicorn: Why Investors Are Backing Midi’s Model for Women’s Health

Virtual women’s health provider Midi Health has reached unicorn status after raising a $100 million Series D, with investors backing its insurance-covered, direct-to-consumer model. The company is positioning itself as a long-term, virtual “hospital without walls” designed to meet women’s health needs across midlife and beyond.

By Katie Adams

Health Tech

Cancer Detection Startup Secures $4M to Expand Access in Underserved Communities

beHuman's $4 million seed round was led by Santé Ventures, with participation from DHVP.io. It will help expand its footprint.

By Marissa Plescia

MedCity Influencers

The $25.7B Healthcare Problem AI Is Finally Solving

Billing frustration isn’t just a provider problem; it’s a patient problem too. Every delayed claim, every error, every confusing denial ultimately affects the person receiving care. Now AI can reduce that friction.

By Roshan Patel

MedCity Influencers

3 blue DNA molecule helixes swirled in circle and bottle with drugs. Genetic engineering, treatment of genetic diseases with medicinal products, medical concept. Low poly wireframe style. pharmacogenetics test

PGx Testing: Specialists Benefit From, and Build Upon Oncology’s Success

Some specialties, like oncology, have been quicker to embrace the promise of pharmacogenomics (PGx), and their successes can serve as a roadmap as others explore the impact it can have on quality, outcomes and patient satisfaction.

By Carla Balch

Health Tech, Startups, Payers, Artificial Intelligence

Coins arranged as a bar chart with a graph line above

Alaffia Health Snags $55M for AI Engine Tackling Healthcare’s Waste Problem

As providers continue to adopt AI in droves, payers are under pressure to modernize their own administrative operations. Alaffia Health says its clinically grounded AI platform can help health plans reduce waste and risk, a bet investors backed this week with a $55 million Series B funding round.

By Katie Adams

Consumer / Employer, Health Tech

Included Health Launches Alternative Plan Design for Employers

Included Health is launching an alternative health plan centered on primary care, AI support, price transparency and easier navigation.

By Marissa Plescia